We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+5.23%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$11.4B
AUM Growth
+$1.51B
Cap. Flow
+$1.57B
Cap. Flow %
13.8%
Top 10 Hldgs %
14.71%
Holding
853
New
18
Increased
633
Reduced
86
Closed
17

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$43.1M
2
KO icon
Coca-Cola
KO
+$28.3M
3
AAPL icon
Apple
AAPL
+$27M
4
T icon
AT&T
T
+$23M
5
SPG icon
Simon Property Group
SPG
+$20.5M

Sector Composition

Rank Sector Weight
1 Financials 14.83%
2 Technology 12.04%
3 Healthcare 10.24%
4 Energy 9.26%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRO
226
DELISTED
Marathon Oil Corporation
MRO
$9.42M 0.08%
270,111
+58,699
+28% +$2.09M
NEE icon
227
NextEra Energy
NEE
$184B
$9.29M 0.08%
463,616
+134,848
+41% +$2.78M
RTN
228
DELISTED
Raytheon Company
RTN
$9.26M 0.08%
120,088
+32,691
+37% +$2.43M
SLF icon
229
Sun Life Financial
SLF
$45.6B
$9.13M 0.08%
286,057
+85,818
+43% +$2.73M
NBL
230
DELISTED
Noble Energy, Inc.
NBL
$9.1M 0.08%
135,831
+31,489
+30% +$2.02M
SO icon
231
Southern Company
SO
$108B
$9.08M 0.08%
220,593
+68,837
+45% +$2.97M
JOY
232
DELISTED
Joy Global Inc
JOY
$9.08M 0.08%
177,871
+7,180
+4% +$366K
TFC icon
233
Truist Financial
TFC
$63.9B
$8.91M 0.08%
264,131
+58,505
+28% +$2.04M
REGN icon
234
Regeneron Pharmaceuticals
REGN
$72.9B
$8.76M 0.08%
28,009
+7,405
+36% +$1.95M
ADM icon
235
Archer Daniels Midland
ADM
$38.7B
$8.72M 0.08%
236,807
+54,345
+30% +$1.98M
SCHW
236
Charles Schwab
SCHW
$182B
$8.68M 0.08%
410,589
+86,051
+27% +$1.87M
CB icon
237
Chubb
CB
$140B
$8.68M 0.08%
92,732
+28,959
+45% +$2.65M
DO
238
DELISTED
Diamond Offshore Drilling
DO
$8.65M 0.08%
138,867
-2,640
-2% -$177K
AMD icon
239
Advanced Micro Devices
AMD
$700B
$8.56M 0.08%
2,253,161
+314,083
+16% +$1.2M
VALE icon
240
Vale
VALE
$62.3B
$8.55M 0.08%
547,561
-21,786
-4% -$322K
VTRS icon
241
Viatris
VTRS
$20.8B
$8.52M 0.07%
223,089
+81,077
+57% +$2.85M
ALXN
242
DELISTED
Alexion Pharmaceuticals
ALXN
$8.49M 0.07%
73,099
+17,545
+32% +$1.92M
R icon
243
Ryder
R
$9.9B
$8.48M 0.07%
142,061
-3,309
-2% -$199K
BSX icon
244
Boston Scientific
BSX
$68.4B
$8.48M 0.07%
722,009
-212,718
-23% -$2.3M
LNKD
245
DELISTED
LinkedIn Corporation
LNKD
$8.42M 0.07%
34,228
+7,758
+29% +$1.75M
ALTR
246
DELISTED
Altera Corp
ALTR
$8.42M 0.07%
226,492
+28,231
+14% +$1.01M
TNL icon
247
Travel + Leisure Co
TNL
$4.76B
$8.39M 0.07%
304,844
+20,648
+7% +$565K
AES icon
248
AES
AES
$10.6B
$8.31M 0.07%
625,363
-33,215
-5% -$426K
FIS icon
249
Fidelity National Information Services
FIS
$24.2B
$8.27M 0.07%
178,060
+17,438
+11% +$791K
CAM
250
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$8.22M 0.07%
140,792
+94,388
+203% +$5.62M

Similar funds

Aviva's Q3 2013 Portfolio in Review

As of Q3 2013, Aviva held 853 positions worth $11.4B, up 15% from $9.89B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aviva deployed $1.57B of net new capital in Q3 2013, opening 18 new positions and adding to 633 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 403,948 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Illinois Tool Works, an estimated $26.5M trimmed.

  • Aviva's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 403,948 shares worth $13.5M.
  • Aviva added most to ExxonMobil in Q3 2013, an estimated $43.1M increase.
  • Aviva's biggest Q3 2013 reduction was Illinois Tool Works, cutting an estimated $26.5M.
  • Aviva fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $9.24M.
  • Aviva's ten largest holdings make up 15% of its $11.4B portfolio in Q3 2013.
  • Aviva opened 18 new positions and closed 17 in Q3 2013.
  • Aviva's portfolio value rose 15% quarter-over-quarter to $11.4B.

Based on Aviva's 13F filing for Q3 2013, filed 13 Nov 2013.